Global Pet Veterinary Drug Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 111

Report ID: 3469

Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global pet veterinary drug market is divided into drugs and biological agents and vaccines according to drugs. According to the ingredients, it is divided into anti-infectives, anti-inflammatory drugs, parasiticides, analgesics and sedatives. Due to the significant growth of the global healthcare industry, global demand for pet veterinary drugs is increasing.
The global Pet Veterinary Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pet Veterinary Drug market based on company, product type, end user and key regions.

This report studies the global market size of Pet Veterinary Drug in key regions like North America, Europe, China and Japan, focuses on the consumption of Pet Veterinary Drug in these regions.
This research report categorizes the global Pet Veterinary Drug market by top players/brands, region, type and end user. This report also studies the global Pet Veterinary Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation

Pet Veterinary Drug market size by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others

Pet Veterinary Drug market size by Applications
Veterinary Hospitals
Veterinary Clinics
Drug Stores

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pet Veterinary Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pet Veterinary Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pet Veterinary Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pet Veterinary Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pet Veterinary Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pet Veterinary Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Pet Veterinary Drug Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pet Veterinary Drug Market Size Growth Rate by Type
1.4.2 Anti-Infectives
1.4.3 Anti-Inflammatory
1.4.4 Parasiticides
1.4.5 Analgesics
1.4.6 Sedatives
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pet Veterinary Drug Market Size Growth Rate by Application
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pet Veterinary Drug Market Size
2.1.1 Global Pet Veterinary Drug Revenue 2014-2025
2.1.2 Global Pet Veterinary Drug Sales 2014-2025
2.2 Pet Veterinary Drug Growth Rate by Regions
2.2.1 Global Pet Veterinary Drug Sales by Regions
2.2.2 Global Pet Veterinary Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pet Veterinary Drug Sales by Manufacturers
3.1.1 Pet Veterinary Drug Sales by Manufacturers
3.1.2 Pet Veterinary Drug Sales Market Share by Manufacturers
3.2 Pet Veterinary Drug Revenue by Manufacturers
3.2.1 Pet Veterinary Drug Revenue by Manufacturers (2014-2019)
3.2.2 Pet Veterinary Drug Revenue Share by Manufacturers (2014-2019)
3.3 Pet Veterinary Drug Price by Manufacturers
3.4 Pet Veterinary Drug Manufacturing Base Distribution, Product Types
3.4.1 Pet Veterinary Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Veterinary Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pet Veterinary Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Pet Veterinary Drug Sales by Type
4.2 Global Pet Veterinary Drug Revenue by Type
4.3 Pet Veterinary Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Pet Veterinary Drug Breakdown Data by Application

6 North America
6.1 North America Pet Veterinary Drug by Country
6.1.1 North America Pet Veterinary Drug Sales by Country
6.1.2 North America Pet Veterinary Drug Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pet Veterinary Drug by Type
6.3 North America Pet Veterinary Drug by Application

7 Europe
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country
7.1.2 Europe Pet Veterinary Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Veterinary Drug by Type
7.3 Europe Pet Veterinary Drug by Application

8 Asia Pacific
8.1 Asia Pacific Pet Veterinary Drug by Country
8.1.1 Asia Pacific Pet Veterinary Drug Sales by Country
8.1.2 Asia Pacific Pet Veterinary Drug Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Pet Veterinary Drug by Type
8.3 Asia Pacific Pet Veterinary Drug by Application

9 Central & South America
9.1 Central & South America Pet Veterinary Drug by Country
9.1.1 Central & South America Pet Veterinary Drug Sales by Country
9.1.2 Central & South America Pet Veterinary Drug Revenue by Country
9.1.3 Brazil
9.2 Central & South America Pet Veterinary Drug by Type
9.3 Central & South America Pet Veterinary Drug by Application

10 Middle East and Africa
10.1 Middle East and Africa Pet Veterinary Drug by Country
10.1.1 Middle East and Africa Pet Veterinary Drug Sales by Country
10.1.2 Middle East and Africa Pet Veterinary Drug Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pet Veterinary Drug by Type
10.3 Middle East and Africa Pet Veterinary Drug by Application

11 Company Profiles
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Details
11.1.2 Company Business Overview
11.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
11.1.5 Boehringer Ingelheim International GmbH Recent Development
11.2 Zoetis Animal Healthcare
11.2.1 Zoetis Animal Healthcare Company Details
11.2.2 Company Business Overview
11.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Products Offered
11.2.5 Zoetis Animal Healthcare Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Company Business Overview
11.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer AG Pet Veterinary Drug Products Offered
11.3.5 Bayer AG Recent Development
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Details
11.4.2 Company Business Overview
11.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Animal Health Pet Veterinary Drug Products Offered
11.4.5 Merck Animal Health Recent Development
11.5 Elanco Animal Health Inc.
11.5.1 Elanco Animal Health Inc. Company Details
11.5.2 Company Business Overview
11.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Products Offered
11.5.5 Elanco Animal Health Inc. Recent Development
11.6 Virbac Group
11.6.1 Virbac Group Company Details
11.6.2 Company Business Overview
11.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Virbac Group Pet Veterinary Drug Products Offered
11.6.5 Virbac Group Recent Development
11.7 Ceva
11.7.1 Ceva Company Details
11.7.2 Company Business Overview
11.7.3 Ceva Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Ceva Pet Veterinary Drug Products Offered
11.7.5 Ceva Recent Development
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Company Details
11.8.2 Company Business Overview
11.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Products Offered
11.8.5 Dechra Pharmaceuticals Plc Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Company Business Overview
11.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Vetoquinol Pet Veterinary Drug Products Offered
11.9.5 Vetoquinol Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Company Details
11.10.2 Company Business Overview
11.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Orion Corporation Pet Veterinary Drug Products Offered
11.10.5 Orion Corporation Recent Development

12 Future Forecast
12.1 Pet Veterinary Drug Market Forecast by Regions
12.1.1 Global Pet Veterinary Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Pet Veterinary Drug Revenue Forecast by Regions 2019-2025
12.2 Pet Veterinary Drug Market Forecast by Type
12.2.1 Global Pet Veterinary Drug Sales Forecast by Type 2019-2025
12.2.2 Global Pet Veterinary Drug Revenue Forecast by Type 2019-2025
12.3 Pet Veterinary Drug Market Forecast by Application
12.4 North America Pet Veterinary Drug Forecast
12.5 Europe Pet Veterinary Drug Forecast
12.6 Asia Pacific Pet Veterinary Drug Forecast
12.7 Central & South America Pet Veterinary Drug Forecast
12.8 Middle East and Africa Pet Veterinary Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Veterinary Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer